A Phase I Study of the Safety, Pharmacokinetics, and Anti-Tumor Activity of TH-302 in Patients With Advanced Solid Tumors

NCT00495144 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
129
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Threshold Pharmaceuticals